SSB heads into Q3 earnings with shorts building and the Street still broadly bullish

SouthState Bank Corporation reports Q3 results on October 22 with short interest climbing steadily through October, analysts trimming targets ahead of the print, and options activity picking up relative to its own recent baseline.

Short interest has been moving in one direction all month. It has risen 15.8% over the past 30 days to 3.25% of the free float, with about half that gain coming in the past week alone (up 3.7%). That is not a crowded short by any measure, but the trend is worth noting: bears have been adding consistently, not in a single spike. The borrow market gives them little friction. Cost to borrow is a negligible 0.47%, down roughly 10% over the month, and availability is extraordinarily loose at over 4,500% of short interest, meaning shares to borrow are abundant. The ORTEX short score has drifted higher too, from 36.3 on October 7 to 37.4 on October 20, a modest but consistent move. Positioning looks cautious rather than aggressive: the bears are leaning in, but the lending market is not under any strain.

Options traders have nudged more defensive ahead of the print, though the move is modest. The put/call ratio hit 0.051 on October 20, about 1.8 standard deviations above its 20-day average of 0.029. It is still an extremely call-heavy book in absolute terms, the 52-week high on the PCR is 4.45, so current levels barely register as protective. The brief spike to 0.077 on October 19 then pulling back suggests some short-dated hedging was placed and partly unwound rather than a sustained shift in sentiment.

The Street remains constructive, but has quietly lowered its sights since the last earnings. Most of the recent analyst activity has been target cuts while maintaining positive ratings. Truist lowered to $113 from $118 in early October, keeping Buy. JP Morgan cut to $120 from $125, also retaining Overweight. TD Cowen trimmed to $116. Only Barclays moved in the other direction, raising to $120. The consensus mean target is $118.64 against a current price of $102.62, implying roughly 16% upside, but the direction of travel in recent weeks has been clearly downward revision. The bull case centres on capital returns: the company's medium-to-long term payout ratio target of 40% to 60% and a strong balance sheet that could support buybacks or future acquisitions. Bears point to regulatory capital constraints and a share price that has been trading below the average repurchase level, which risks pushing the total payout ratio above the stated range. The stock trades at a P/E of just over 10 and near book value (P/B 0.99), both modest multiples for a regional bank with a $9.8 billion market cap. The dividend score ranks in the 87th percentile across the ORTEX universe, reflecting the income profile that underpins the bull case.

FDIC call report data from the Federal Deposit Insurance Corporation shows two consecutive streaks worth noting. Total assets have risen for nine straight quarters, reaching $68.8 billion as of the April 2026 period. Net loans and leases have also increased for nine consecutive quarters, at $50.7 billion. The FDIC data series has not yet been measured to lead SSB's reported figures (there is not enough history to test), so these reads are colour rather than a leading signal. But nine quarters of unbroken balance sheet growth is a concrete fact heading into the print.

The institutional register shows broad passive accumulation. BlackRock reported 10.1% of shares as of September 30, having added 352,714 shares in the period. Dimensional Fund Advisors added 169,834 shares over the same quarter. Wellington Management increased its position by over 200,000 shares. No 13D activist is on the register. On the insider side, the most recent open-market transaction was a discretionary sale: CFO William Matthews sold 4,000 shares at $108.93 in August, about $435,000 worth. That was not under a 10b5-1 plan. Other insider activity in August was gifts and compensation awards rather than open-market buying, giving a net 90-day insider position of around negative 34,800 shares. No conviction buying from the C-suite is visible in the data.

Peers have had a solid week. ONB gained 2.9%, UBSI rose 3.2%, and FNB was the standout at up 3.6%. SSB's 2.8% week broadly matches the peer group, suggesting the sector has been in recovery mode rather than SSB doing anything idiosyncratic. What to watch on October 22 is whether loan growth continues its nine-quarter run and whether management guides on the payout ratio, given that the buyback pace has been running above the long-term target range.